FDA
label_change
· 2025-04-24
FDA Approved: ZYRTEC HIVES — Supplemental Application (Kenvue Brands LLC)
Summary
FDA supplemental application for ZYRTEC HIVES to support labeling for cetirizine hydrochloride in the treatment of urticaria (hives).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ZYRTEC HIVES (CETIRIZINE HYDROCHLORIDE)